Group 1 - The company announced the resignation of its General Manager, He Wei, who will focus on his role as Chairman to enhance the company's governance structure and decision-making efficiency [2][3] - He Wei remains a significant shareholder, holding 30,327,379 shares directly and 5,146,921 shares indirectly, and will continue to serve as Chairman and on various committees [3] - The company appointed He Xingru as the new General Manager, effective from the date of the board's approval, to oversee daily operations [4][13] Group 2 - The company held its 14th meeting of the third board on December 5, 2025, where it approved the first grant of restricted stock under the 2025 incentive plan, awarding 5.1 million shares to 240 eligible participants at a price of 13.00 yuan per share [10][17] - The incentive plan aims to enhance employee cohesion and operational efficiency, with performance targets set for the years 2025 to 2027 [23][35] - The plan includes specific conditions for stock vesting, which are tied to the company's performance metrics and individual assessments [24][36]
辽宁何氏眼科医院集团股份有限公司 关于变更公司总经理的公告